Clinical Trials Logo

Clinical Trial Summary

The overall aim in this "proof-of-concept" study is to evaluate if a diet concept, based on foods that have individually been reported to beneficially affect gut microbiota in fact has an effect on gut microbiota composition and activity among healthy and obese subjects and whether the effects are associated with altered cardiometabolic risk factors. The aim is further to investigate if such alterations are reflected in changes of the fecal and plasma metabolome. In total, 40 men and women, who meet all the inclusion criteria and none of the exclusion criteria will be invited to participate in the study. The participants will follow an intervention diet for 6 weeks and a control diet for 6 weeks, with a 6-week wash-out period in between and will be randomized to either begin with the intervention diet or the control diet. The study will be running over 18 weeks (including a 6-week wash-out period) and it will include 9 visits at the clinic.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05112276
Study type Interventional
Source Chalmers University of Technology
Contact
Status Completed
Phase N/A
Start date October 27, 2021
Completion date February 25, 2023